Balaxi Pharmaceuticals
Balaxi Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Balaxi Pharmaceuticals
Start SIPBalaxi Pharmaceuticals Investment Rating
-
Master Rating:
-
Balaxi Pharmaceuticals has an operating revenue of Rs. 344.85 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 20% is great, ROE of 42% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 74 which is FAIR indicating the recent price performance, Buyer Demand at D which indicates heavy supply, Group Rank of 83 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 23 | 28 | 26 | 21 |
| Operating Expenses Qtr Cr | 20 | 25 | 22 | 17 |
| Operating Profit Qtr Cr | 4 | 4 | 4 | 4 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 1 | 2 | 1 | 1 |
| Net Profit Qtr Cr | 4 | 4 | 5 | 4 |
Balaxi Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 1
- Bearish Moving Average
- ___
- 15
- 20 Day
- 539.97
- 50 Day
- 546.16
- 100 Day
- 550.48
- 200 Day
- 538.56
- 20 Day
- 541.11
- 50 Day
- 541.17
- 100 Day
- 566.37
- 200 Day
- 529.45
Balaxi Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 543.77 |
| Second Resistance | 555.94 |
| Third Resistance | 572.77 |
| RSI | 46.32 |
| MFI | 45.84 |
| MACD Single Line | -0.61 |
| MACD | -1.01 |
| Support | |
|---|---|
| First Resistance | 514.77 |
| Second Resistance | 497.94 |
| Third Resistance | 485.77 |
Balaxi Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 3,571 | 297,714 | 83.37 |
| Week | 3,171 | 256,430 | 80.88 |
| 1 Month | 2,196 | 159,675 | 72.7 |
| 6 Month | 3,062 | 221,507 | 72.35 |
Balaxi Pharmaceuticals Result Highlights
Balaxi Pharmaceuticals Synopsis
NSE-Medical-Generic Drugs
Balaxi Pharmaceutica is involved in the business activities of Other specialized wholesale. Company’s Total Operating Revenue is Rs. 101.29 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2022. Balaxi Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 28/09/1942 and has its registered office in the State of Kerala, India. Company’s Corporate Identification Number(CIN) is L25191TG1942PLC121598 and registration number is 000045.| Market Cap | 540 |
| Sales | 98 |
| Shares in Float | 0.27 |
| No of funds | 4 |
| Yield |
| Book Value | 9.18 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | |
| Alpha | 0.16 |
| Beta | 0.84 |
Balaxi Pharmaceuticals
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 72.69% | 72.86% | 72.86% | |
| Foreign Portfolio Investors | 18.96% | 19% | 19% | |
| Financial Institutions/ Banks | 0.03% | 0.03% | 0.03% | |
| Individual Investors | 5.11% | 5% | ||
| Others | 3.21% | 3.11% | 8.11% |
Balaxi Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Ashish Maheshwari | Managing Director |
| Mrs. Minoshi Maheshwari | Non Executive Director |
| Mr. M Srinivas Rao | Independent Director |
| Mr. Purnima Singh Kamble | Independent Director |
| Mr. Kunal M Bhakta | Independent Director |
| Mr. Gandhi Gamji | Independent Director |
Balaxi Pharmaceuticals Forecast
Price Estimates
Balaxi Pharmaceuticals FAQs
What is Share Price of Balaxi Pharmaceuticals ?
Balaxi Pharmaceuticals share price is ₹540 As on 29 March, 2023 | 15:15
What is the Market Cap of Balaxi Pharmaceuticals ?
The Market Cap of Balaxi Pharmaceuticals is ₹549.8 Cr As on 29 March, 2023 | 15:15
What is the P/E ratio of Balaxi Pharmaceuticals ?
The P/E ratio of Balaxi Pharmaceuticals is 10.7 As on 29 March, 2023 | 15:15
What is the PB ratio of Balaxi Pharmaceuticals ?
The PB ratio of Balaxi Pharmaceuticals is 4.9 As on 29 March, 2023 | 15:15